Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 156.59% | -28.77% | -- | 19.04% | -72.29% |
| Total Depreciation and Amortization | -57.69% | 456.47% | -- | -19.70% | 219.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,144.65% | 2.07% | -- | 155.12% | -111.31% |
| Change in Net Operating Assets | -485.90% | 104.41% | -- | 30.68% | 412.35% |
| Cash from Operations | 91.54% | 20.33% | 47.07% | 51.53% | 0.01% |
| Capital Expenditure | 85.93% | 60.71% | -- | -547.12% | -4,235.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.81% | 79.76% | -- | -49.31% | 333.86% |
| Cash from Investing | -131.25% | 78.37% | -45.27% | -95.40% | 296.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -4,300.00% |
| Issuance of Common Stock | 42.10% | -100.00% | -- | -- | 24.70% |
| Repurchase of Common Stock | -180.00% | -60.00% | -- | 99.58% | 74.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.14% | -5,500.00% | 100.38% | 99.77% | -5,335.69% |
| Foreign Exchange rate Adjustments | 62.55% | 50.25% | -- | 1,800.00% | -216.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.80% | 50.65% | 144.84% | -106.51% | -54.27% |